A new Atlas of the rarest humans on Earth, the supercentenarians who lived past 110, is rewriting what science thought it knew about aging. Inside George Church’s four-front war on…
GUARDIAN, BEACONS, BabySeq2, BeginNGS, and the NHS Generation Study are running in parallel in 2026. Inside the 12-fold detection signal from Columbia, the $14.4 million NIH multi-state pilot, and what…
A casual conversation between two Mayo Clinic graduate students sparked a discovery that could solve one of longevity medicine’s most stubborn problems: finding the cells that silently drive aging, cancer,…
For two decades after the Human Genome Project, the promise of personalized medicine outran the data. In 2026, that gap is finally closing. Polygenic risk scores built from millions of…
A convergence of preclinical and clinical evidence — from a landmark Cell Metabolism mouse study to the first human epigenetic clock trial — is building the case that GLP-1 receptor…
A new generation of liquid biopsy tests is trying to do something cancer screening has never done before: catch fifty kinds of cancer from a single tube of blood, often…
A Nature Medicine study of 44,498 people used 2,916 blood proteins to measure the biological age of 11 separate organs, finding that a biologically young brain and immune system together…
An estimated 1.4 billion people globally carry elevated lipoprotein(a), a genetically inherited cardiovascular risk factor that statins do not lower. Inside the biology of Lp(a), why the science went quiet…
A landmark 2026 Science study from the Weizmann Institute finds lifespan is roughly 50% heritable — more than double previous estimates. Inside the methodology, what it means for longevity research,…
The most anticipated longevity drug trial in a generation has delivered its full one-year results. Here is what rapamycin actually did to lean muscle, pain, biological age, and overall healthspan…
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.